Clinical Trial Update: Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the oral absorbent AST-120 in late-stage chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• AST-120 (AST-120)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Chronic Kidney Disease, AST-120 | Phase 4 | Status: COMPLETED